Is hemophilia A gene therapy available in China?

Yes. AAV gene therapy for hemophilia A is available through a translational application pathway in the Boao Lecheng Pilot Zone at Hainan Haikong Le City Hospital. This pathway does not mean nationwide approval.

How much does hemophilia A gene therapy cost in China?

The estimated cost is approximately US$101,200 per session. Patients should confirm final pricing and exactly what is included directly with the hospital.

Who may qualify for hemophilia A gene therapy?

Individuals with confirmed hemophilia A and congenital FVIII deficiency may be considered. Age, liver function, AAV neutralizing antibodies, previous medication history, and inhibitors are among the factors assessed by the attending physician.

Can international patients explore AAV gene therapy in China?

Yes. International patients can seek an assessment through the designated hospital, subject to medical eligibility and the requirements of the Boao Lecheng access pathway.

top of page

ChinaCurelink
a MedeboundHEALTH Company

FREE CONSULTATION

AAV Gene Therapy for Hemophilia A in China: 2026 International Patient Guide

ChinaCureLink

Fri Aug 28 2026

6 min read

Widget Didn’t Load

Check your internet and refresh this page.

If that doesn’t work, contact us.

bottom of page